H

hVIVO Services Limited | Queen Mary BioEnterprises Innovation Centre

Research site

(Unclaimed)

Location

42 New Road, London, London, City of, England

Site insights

Top conditions

Top treatments

Neumifil

CC-42344

JNJ-64281802

EDP-323

JNJ-64417184

Palivizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 12 total trials

Influenza Viral Challenge Study of CC-42344 in Healthy Participants

Participants in this study will be given either CC-42344 (one of two dose levels) or placebo orally for 5 days after receiving an influenza (flu) cha...

Enrolling

Influenza A

Drug: Placebo

Drug: CC-42344

Study of SAB-176 in Healthy Adult Participants

Healthy adult participants will be challenged with the H1N1 Influenza virus and then treated with either SAB-176 or placebo.

Active, not recruiting

Influenza A H1N1

Other: Placebo

Biological: SAB-176

Trial sponsors

C

H

P

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms